Stay updated on Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.

Latest updates to the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new Revision: v3.4.2 is shown, and an outdated government funding operating-status notice has been removed.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a banner notice about a lapse in government funding and the NIH Clinical Center's status with links for updates. The page revision label was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page adds a glossary toggle, a 'Last Update Submitted that Met QC Criteria' indicator, 'No FEAR Act Data' and 'Revision: v3.4.0', while removing the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' elements.SummaryDifference0.2%

- Check42 days agoChange DetectedMinor revision history updates show Revision: v3.3.4 added and Revision: v3.3.3 removed, which do not affect core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedA centralized Locations section now lists all study sites by state (Arizona, California, Florida, Indiana, Kentucky, Missouri, New York, Ohio, Oregon, Pennsylvania, Rhode Island, Virginia), replacing the previous per-state location headers. The page also shows an updated Revision: v3.3.3.SummaryDifference1%

- Check85 days agoChange DetectedThe page shows a minor revision update from Revision: v3.3.1 to v3.3.2; no study content, eligibility criteria, or results are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.